Fact CheckerSign in

NCT07765069Not yet recruiting

Positioning in RT - Supine vs. Upright

Preferences and Perspectives on Supine vs. Upright Positioning in Radiation Therapy

Source: ClinicalTrials.gov · Last updated 4 Nov 2026

Brief summary (registry, in English)

This is a single-center, non-therapeutic prospective pilot cohort study evaluating patient-reported comfort levels between upright and supine positioning in patients receiving radiation therapy across all age groups using a concurrent mixed-methods design. Following standard-of-care RT planning or delivery in the conventional supine position, patients and caregivers will complete a questionnaire evaluating the current treatment position. Patients will then be positioned upright in a chair, using similar immobilization to their supine setup when feasible. This position will be maintained for up to 15 minutes, as tolerated by the patient. During the upright positioning session, patients and caregivers will be asked open-ended questions exploring their perceptions of comfort, stability, and overall experience with the upright chair. No radiation or therapeutic intervention will be delivered during the upright session; the upright positioning procedure is non-therapeutic and conducted solely for assessment purposes. Patients and their caregivers will again be asked to complete a questionnaire evaluating the upright position. Key stakeholders involved in RT (including Radiation Therapists, Registered Nurses, Radiation Oncologists, or Medical Physicists), will participate in one semi-structured interview to explore perspectives on supine versus upright positioning for RT. Each interview will take up to 60 minutes and will be conducted in-person or virtual using UHN's Microsoft Teams. All sessions will be audio recorded and transcribed on the UHN Microsoft cloud, which is encrypted and stored securely.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
105 (estimated)
First submitted
9 Jun 2026
Start date
1 Dec 2026
Primary completion date
30 Nov 2027
Lead sponsor
University Health Network, Toronto
NCT number
NCT07765069

What you commit to

  • Study type: Observational
  • Planned participants: 105
  • From 1 Dec 2026 to the primary completion date, 30 Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

  • Pediatric and adult patients aged 3 years and older, undergoing radiation therapy as part of standard clinical care.
  • Lansky or Karnofsky score 40 or greater
  • Ability to provide informed consent (or if appropriate, provided by parent or legal guardian).
  • Ability to understand and speak English or with appropriate assistance

Age in the registry: 3 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Princess Margaret Cancer Centre
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.